— Know what they know.
Not Investment Advice

KRRO NASDAQ

Korro Bio, Inc.
1W: +1.1% 1M: -19.9% 3M: +0.8% YTD: +39.1% 1Y: -30.8% 3Y: -37.8% 5Y: -97.4%
$11.61
+0.41 (+3.66%)
 
Weekly Expected Move ±8.7%
$8 $9 $10 $11 $12
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 37 · $115.6M mcap · 6M float · 3.14% daily turnover · Short 58% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
34.9 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -330.7%
Cost Advantage ★
45
Intangibles
37
Switching Cost
30
Network Effect
39
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. KRRO has No discernible competitive edge (34.9/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -330.7% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$15
Low
$15
Avg Target
$15
High
Based on 1 analyst since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$20.00
Analysts3
Consensus Change History
DateFieldFromTo
2026-01-29 consensus Hold Buy
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-19 H.C. Wainwright Mitchell Kapoor $20 $15 -5 +50.5% $9.97
2026-03-13 Cantor Fitzgerald Steve Seehouse $21 $22 +1 +91.3% $11.50
2026-03-13 Raymond James Ryan Deschner $18 $23 +5 +100.0% $11.50
2026-02-18 Raymond James Initiated $18 +60.2% $11.23
2026-01-29 H.C. Wainwright $115 $20 -95 +71.1% $11.69
2026-01-29 Chardan Capital $25 $15 -10 +28.3% $11.69
2026-01-28 Piper Sandler Yasmeen Rahimi Initiated $30 +156.6% $11.69
2026-01-28 William Blair Myles Minter Initiated $10 -10.5% $11.17
2026-01-28 Oppenheimer Initiated $22 +104.8% $10.74
2026-01-27 Cantor Fitzgerald Steve Seedhouse Initiated $21 +95.5% $10.74
2025-04-16 Chardan Capital Keay Nakae Initiated $25 +85.7% $13.46
2024-10-21 RBC Capital Luca Issi $90 $105 +15 +36.5% $76.94
2024-05-15 BMO Capital Kostas Biliouris Initiated $120 +139.8% $50.05
2024-03-28 H.C. Wainwright Initiated $115 +29.9% $88.53
2024-03-27 RBC Capital Initiated $90 +0.2% $89.83

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. KRRO receives an overall rating of C. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-07 C- C
2026-03-13 C C-
2026-01-12 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

Grade A+
Profitability
Balance Sheet
76
Earnings Quality
18
Growth
16
Value
30
Momentum
23
Safety
0
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-5.06
Distress Zone
Piotroski F-Score
2/9
Beneish M-Score
Ohlson O-Score
-1.66
Bankruptcy prob: 16.0%
Moderate
Credit Rating
BB
Score: 40.6/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.62x
Accruals: -25.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. KRRO scores -5.06, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. KRRO scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. KRRO's implied 16.0% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. KRRO receives an estimated rating of BB (score: 40.6/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.19x
PEG
0.04x
P/S
30.08x
P/B
1.13x
P/FCF
-1.86x
P/OCF
EV/EBITDA
-1.27x
EV/Revenue
25.93x
EV/EBIT
-1.22x
EV/FCF
-1.41x
Earnings Yield
-86.44%
FCF Yield
-53.77%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. KRRO currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.006
NI / EBT
×
Interest Burden
1.382
EBT / EBIT
×
EBIT Margin
-21.234
EBIT / Rev
×
Asset Turnover
0.023
Rev / Assets
×
Equity Multiplier
1.604
Assets / Equity
=
ROE
-107.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. KRRO's ROE of -107.1% is driven by Asset Turnover (0.023), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1668 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$11.61
Median 1Y
$2.17
5th Pctile
$0.17
95th Pctile
$27.45
Ann. Volatility
145.8%
Analyst Target
$20.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
58
-44.2% YoY
Revenue / Employee
$110,207
Rev: $6,392,000
Profit / Employee
$-2,021,724
NI: $-117,260,000
SGA / Employee
$485,500
Avg labor cost proxy
R&D / Employee
$1,130,603
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -29.8% -40.8% -52.4% -54.2% -51.4% -47.9% -4.6% -4.4% -4.7% -4.6% -2.3% -2.3% -2.4% -2.5% -50.6% -52.9% -55.3% -53.5% -1.1% -1.1% -1.07%
ROA -22.0% -30.1% -37.6% -39.0% -36.9% -34.4% -56.6% -53.7% -57.2% -56.4% -55.0% -54.9% -57.8% -59.4% -37.3% -39.0% -40.8% -39.5% -69.0% -66.8% -66.81%
ROIC -2.3% -3.2% -1.5% -1.5% -1.4% -1.3% -4.9% -4.7% -5.1% -5.0% -1.8% -1.9% -2.0% -2.0% -91.8% -95.4% -98.4% -94.4% -3.5% -3.3% -3.31%
ROCE -22.3% -30.6% -48.2% -50.0% -47.5% -44.3% -1.1% -1.1% -1.1% -1.1% -40.9% -41.8% -45.0% -47.4% -43.5% -45.2% -46.6% -44.2% -84.8% -80.3% -80.32%
Gross Margin 1.0% 1.0% 1.0% 1.0% 1.0% 49.8%
Operating Margin -1.9% -10.1% -9.8% -18.6% -17.6% -12.3%
Net Margin -1.9% -9.3% -9.2% -17.7% -16.6% -38.7%
EBITDA Margin -1.7% -9.6% -9.3% -17.8% -15.5% -11.8%
FCF Margin -2.2% -3.3% -5.6% -7.5% -34.3% -15.6% -11.8% -9.5% -12.4% -18.4% -18.38%
OCF Margin -1.9% -3.0% -5.4% -7.2% -26.5% -13.0% -10.7% -9.3% -12.3% -18.3% -18.27%
ROE 3Y Avg snapshot only -1.08%
ROA 3Y Avg snapshot only -58.41%
ROIC 3Y Avg snapshot only -1.43%
ROIC Economic snapshot only -68.93%
Cash ROA snapshot only -61.83%
Cash ROIC snapshot only -3.55%
CROIC snapshot only -3.57%
NOPAT Margin snapshot only -17.02%
Pretax Margin snapshot only -29.35%
R&D / Revenue snapshot only 15.30%
SGA / Revenue snapshot only 7.93%
SBC / Revenue snapshot only 1.25%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -6.36 -3.31 -2.10 -0.84 -0.63 -6.04 -14.18 -1.98 -1.30 -1.45 -4.73 -8.90 -3.57 -3.54 -4.06 -1.87 -1.28 -5.09 -0.64 -1.16 -1.186
P/S Ratio 9.67 10.13 12.62 7.84 149.54 33.89 18.67 61.02 11.77 34.17 30.078
P/B Ratio 1.77 1.26 1.36 0.56 0.40 3.58 -10.50 -1.39 -0.97 -1.07 2.26 4.25 1.79 1.83 2.12 1.02 0.73 2.80 1.46 2.55 1.126
P/FCF -4.45 -3.03 -2.25 -1.05 -0.83 -7.86 -17.98 -2.23 -1.41 -1.54 -3.84 -6.79 -2.83 -2.66 -4.36 -2.18 -1.59 -6.40 -0.95 -1.86 -1.860
P/OCF
EV/EBITDA -3.30 -0.99 -1.15 0.14 0.42 -5.27 -16.84 -3.81 -2.99 -3.15 -3.18 -7.28 -1.96 -1.92 -2.92 -0.90 -0.38 -4.17 -0.53 -1.27 -1.275
EV/Revenue 4.73 2.87 6.57 -1.20 113.73 17.02 5.72 49.98 6.82 25.93 25.931
EV/EBIT -3.13 -0.95 -1.10 0.13 0.39 -4.97 -15.83 -3.60 -2.82 -2.98 -3.04 -6.97 -1.88 -1.86 -2.81 -0.86 -0.36 -3.95 -0.51 -1.22 -1.221
EV/FCF -2.17 -0.86 -1.17 0.16 0.52 -6.43 -19.91 -4.03 -3.03 -3.16 -2.51 -5.54 -1.59 -1.53 -3.31 -1.09 -0.49 -5.25 -0.55 -1.41 -1.411
Earnings Yield -15.7% -30.2% -47.7% -1.2% -1.6% -16.6% -7.0% -50.6% -77.0% -69.1% -21.1% -11.2% -28.0% -28.2% -24.6% -53.5% -77.9% -19.7% -1.6% -86.4% -86.44%
FCF Yield -22.5% -33.0% -44.5% -95.3% -1.2% -12.7% -5.6% -44.9% -71.0% -64.8% -26.0% -14.7% -35.4% -37.5% -23.0% -45.9% -63.0% -15.6% -1.1% -53.8% -53.77%
PEG Ratio snapshot only 0.042
Price/Tangible Book snapshot only 2.552
EV/Gross Profit snapshot only 35.417
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 8.45 8.45 11.79 11.79 11.79 11.79 6.56 6.56 6.56 6.56 8.87 8.87 8.87 8.87 8.79 8.79 8.79 8.79 6.90 6.90 6.901
Quick Ratio 8.45 8.45 11.79 11.79 11.79 11.79 6.56 6.56 6.56 6.56 8.87 8.87 8.87 8.87 8.79 8.79 8.79 8.79 6.90 6.90 6.901
Debt/Equity 0.24 0.24 0.35 0.35 0.35 0.35 -1.69 -1.69 -1.69 -1.69 0.20 0.20 0.20 0.20 0.28 0.28 0.28 0.28 0.85 0.85 0.845
Net Debt/Equity -0.91 -0.91 -0.65 -0.65 -0.65 -0.65 -0.78 -0.78 -0.78 -0.78 -0.51 -0.51 -0.51 -0.51 -0.62 -0.62 -0.616
Debt/Assets 0.17 0.17 0.25 0.25 0.25 0.25 2.26 2.26 2.26 2.26 0.15 0.15 0.15 0.15 0.20 0.20 0.20 0.20 0.38 0.38 0.383
Debt/EBITDA -0.91 -0.66 -0.57 -0.55 -0.58 -0.63 -2.44 -2.56 -2.41 -2.43 -0.42 -0.41 -0.38 -0.36 -0.51 -0.49 -0.48 -0.51 -0.53 -0.56 -0.556
Net Debt/EBITDA 3.45 2.50 1.06 1.03 1.08 1.17 -1.63 -1.70 -1.60 -1.61 1.68 1.64 1.52 1.44 0.92 0.89 0.87 0.92 0.39 0.41 0.405
Interest Coverage -133.01 -125.17 -109.83 -159.24 -227.06 -173.00 -126.46 -80.47 -85.65 -122.08 -290.89
Equity Multiplier 1.38 1.38 1.42 1.42 1.42 1.42 -0.74 -0.74 -0.74 -0.74 1.30 1.30 1.30 1.30 1.41 1.41 1.41 1.41 2.21 2.21 2.207
Cash Ratio snapshot only 6.296
Cash to Debt snapshot only 1.728
FCF to Debt snapshot only -1.624
Defensive Interval snapshot only 324.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.14 0.10 0.06 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.03 0.03 0.04 0.02 0.023
Inventory Turnover
Receivables Turnover 61.60 41.95 58.13 38.91 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.68 5.69 7.41 8.69 4.80 2.88 2.883
Payables Turnover 7.69 4.58 1.64 0.83 0.83 0.92 1.41 1.22 1.56 1.47 0.54 0.37 0.19 0.00 0.00 0.00 0.00 0.00 0.23 0.36 0.365
DSO 6 9 6 9 136 64 49 42 76 127 126.6 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 47 80 223 438 438 396 259 299 233 249 682 983 1963 1587 1001 1000.8 days
Cash Conversion Cycle -42 -71 -216 -429 -1511 -874 -874.2 days
Fixed Asset Turnover snapshot only 0.237
Cash Velocity snapshot only 0.051
Capital Intensity snapshot only 29.543
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 72.1% -24.3% -62.0% -72.6% -1.0% -1.0% -1.0% -1.0% 1.8% -20.3% -20.31%
Net Income -2.3% -2.4% -2.2% -1.1% -55.0% -5.5% 13.4% 20.7% 10.7% 5.6% -10.7% -16.6% -15.0% -20.1% -3.0% -7.7% -7.1% -0.7% -40.3% -29.8% -29.84%
EPS -2.0% -2.2% -2.1% -1.0% -51.7% 86.1% 88.9% 89.9% 88.8% 13.7% 25.4% 20.5% 28.8% 26.2% 7.5% 7.9% -2.5% 0.3% -33.2% -5.1% -5.05%
FCF -50.2% -27.9% -52.3% -3.1% 17.7% 25.8% 26.8% 12.3% -8.3% -15.2% -72.9% -72.3% -57.6% -70.1% 22.0% 29.4% 31.4% 39.8% -1.4% 5.9% 5.92%
EBITDA -2.3% -2.4% -2.2% -1.1% -55.7% -4.1% 14.6% 20.8% 11.8% 5.2% -15.5% -23.9% -26.3% -34.3% -11.9% -13.0% -7.3% 4.4% 7.3% 14.5% 14.51%
Op. Income -1.9% -2.1% -2.1% -1.1% -55.1% -7.0% 10.9% 17.6% 6.0% 1.8% -13.9% -20.9% -17.8% -24.9% -7.7% -10.1% -7.6% 1.3% 5.0% 13.3% 13.32%
OCF Growth snapshot only -12.05%
Asset Growth snapshot only -49.83%
Equity Growth snapshot only -67.93%
Debt Growth snapshot only -2.86%
Shares Change snapshot only 23.60%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -45.6% -20.0%
Revenue 5Y -13.6% -16.6% -21.1% -25.3% -29.6% -35.5% -35.48%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y -32.2% -6.9%
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y -30.9% -30.9% -30.9% -30.9% -5.7% -5.7% -5.7% -5.7% 6.9% 6.9% 6.9% 6.9% 15.5% 15.5% 15.46%
Assets 5Y 0.3% 0.3% 0.3% 0.3% -15.6% -15.6% -15.58%
Equity 3Y -4.1% -4.1% -4.1% -4.1% 7.0% 7.0% 7.0% 7.0%
Book Value 3Y -57.9% -57.8% -59.3% -59.7% -54.4% -55.0% -55.0% -12.0%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.08 0.01 0.33 0.92 0.08 0.29 0.53 0.88 0.85 0.80 0.60 0.60 0.19 0.53 0.41 0.47 0.51 0.54 0.535
Earnings Stability 0.93 0.99 1.00 0.80 0.80 0.73 0.78 0.59 0.76 0.70 0.76 0.65 0.72 0.70 0.76 0.65 0.70 0.69 0.694
Margin Stability 0.00 0.00 0.00 0.00 0.01 0.07 0.13 0.10 0.103
Rev. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.98 0.95 0.92 0.96 0.98 0.96 0.93 0.94 0.92 0.99 0.97 0.97 1.00 0.84 0.88 0.881
Earnings Smoothness
ROE Trend -0.56 -0.53 -0.45 -0.34 -1.78 -1.70 -1.695
Gross Margin Trend 0.52 0.64
FCF Margin Trend -1.71 -4.81
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.28 0.99 0.90 0.77 0.74 0.76 0.71 0.78 0.77 0.78 1.06 1.09 1.03 1.05 0.72 0.72 0.74 0.77 0.67 0.62 0.618
FCF/OCF 1.12 1.10 1.04 1.04 1.02 1.02 1.12 1.14 1.19 1.20 1.16 1.20 1.22 1.26 1.30 1.20 1.10 1.03 1.01 1.01 1.006
FCF/Net Income snapshot only 0.622
CapEx/Revenue 22.6% 30.3% 20.7% 25.3% 7.9% 2.6% 1.0% 25.6% 8.1% 10.9% 10.93%
CapEx/Depreciation snapshot only 0.122
Accruals Ratio 0.06 -0.00 -0.04 -0.09 -0.09 -0.08 -0.17 -0.12 -0.13 -0.12 0.03 0.05 0.02 0.03 -0.10 -0.11 -0.11 -0.09 -0.23 -0.25 -0.255
Sloan Accruals snapshot only -0.292
Cash Flow Adequacy snapshot only -167.102
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -12.3% -0.7% -0.8% -1.3% -1.3% -0.1% -0.0% -0.1% -0.1% -0.0% -42.6% -22.7% -76.0% -74.6% -20.4% -42.5% -1.6% -0.3% -0.9% -67.6% -67.58%
Total Shareholder Return -12.3% -0.7% -0.8% -1.3% -1.3% -0.1% -0.0% -0.1% -0.1% -0.0% -42.6% -22.7% -76.0% -74.6% -20.4% -42.5% -1.6% -0.3% -0.9% -67.6% -67.58%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.006
Interest Burden (EBT/EBIT) 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.00 0.98 0.96 0.94 0.92 0.91 0.91 0.93 0.95 1.35 1.38 1.382
EBIT Margin -1.51 -3.03 -5.96 -9.23 -40.47 -19.80 -15.69 -12.66 -13.48 -21.23 -21.234
Asset Turnover 0.14 0.10 0.06 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.03 0.03 0.04 0.02 0.023
Equity Multiplier 1.36 1.36 1.39 1.39 1.39 1.39 8.15 8.15 8.15 8.15 4.17 4.17 4.17 4.17 1.36 1.36 1.36 1.36 1.60 1.60 1.604
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-78.28 $-106.56 $-122.39 $-125.96 $-118.77 $-14.82 $-13.57 $-12.73 $-13.33 $-12.78 $-10.13 $-10.12 $-9.49 $-9.44 $-9.37 $-9.31 $-9.73 $-9.41 $-12.48 $-9.79 $-9.79
Book Value/Share $281.10 $279.39 $189.07 $187.91 $187.02 $25.02 $-18.33 $-18.12 $-17.80 $-17.31 $21.20 $21.19 $18.91 $18.26 $17.98 $17.09 $17.08 $17.08 $5.47 $4.43 $10.31
Tangible Book/Share $281.10 $279.39 $189.07 $187.91 $187.02 $25.02 $-18.33 $-18.12 $-17.80 $-17.31 $21.20 $21.19 $18.91 $18.26 $17.98 $17.09 $17.08 $17.08 $5.47 $4.43 $4.43
Revenue/Share $51.50 $34.86 $20.33 $13.53 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.25 $0.51 $0.67 $0.78 $0.68 $0.33 $0.33
FCF/Share $-111.97 $-116.51 $-114.14 $-100.99 $-90.21 $-11.39 $-10.70 $-11.29 $-12.28 $-11.99 $-12.48 $-13.26 $-11.99 $-12.54 $-8.74 $-8.00 $-7.87 $-7.48 $-8.42 $-6.09 $-6.09
OCF/Share $-100.34 $-105.96 $-109.92 $-97.57 $-88.36 $-11.21 $-9.57 $-9.89 $-10.28 $-10.00 $-10.74 $-11.01 $-9.81 $-9.94 $-6.73 $-6.67 $-7.16 $-7.28 $-8.36 $-6.05 $-6.05
Cash/Share $321.78 $319.81 $188.90 $187.74 $186.85 $25.00 $10.34 $10.22 $10.04 $9.76 $20.73 $20.72 $18.49 $17.86 $14.14 $13.44 $13.43 $13.43 $8.00 $6.48 $9.83
EBITDA/Share $-73.78 $-101.24 $-115.72 $-118.43 $-112.43 $-13.89 $-12.65 $-11.95 $-12.47 $-12.04 $-9.85 $-10.09 $-9.75 $-9.94 $-9.90 $-9.74 $-10.01 $-9.42 $-8.72 $-6.74 $-6.74
Debt/Share $67.17 $66.76 $65.90 $65.49 $65.18 $8.72 $30.90 $30.56 $30.01 $29.20 $4.14 $4.14 $3.70 $3.57 $5.02 $4.77 $4.77 $4.77 $4.63 $3.75 $3.75
Net Debt/Share $-254.61 $-253.05 $-123.00 $-122.25 $-121.67 $-16.28 $20.57 $20.34 $19.97 $19.43 $-16.58 $-16.58 $-14.79 $-14.29 $-9.12 $-8.67 $-8.66 $-8.66 $-3.37 $-2.73 $-2.73
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -5.059
Altman Z-Prime snapshot only -9.562
Piotroski F-Score 4 3 2 2 2 2 1 1 1 1 3 3 3 3 3 3 3 4 2 2 2
Beneish M-Score 2.50 -4.43
Ohlson O-Score snapshot only -1.656
ROIC (Greenblatt) snapshot only -94.14%
Net-Net WC snapshot only $1.75
EVA snapshot only $-67355720.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB
Credit Score 48.93 39.30 29.32 29.87 29.99 56.21 20.00 20.00 20.00 20.00 55.03 76.44 59.91 59.72 48.66 43.07 42.94 53.00 40.91 40.57 40.567
Credit Grade snapshot only 12
Credit Trend snapshot only -2.503
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 34
Sector Credit Rank snapshot only 32

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms